Special Issue "Cytoprotective Effects of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Related Peptides"
Deadline for manuscript submissions: 30 April 2021.
Interests: PACAP; apoptosis; inflammation; cellular protection; vip; secretin; glucagon
Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide discovered more than thirty years ago from hypothalamic extracts. It belongs to a big peptide family, the vasoactive intestinal peptide (VIP), secretin, glucagon peptide family, acting through G protein-coupled receptors. Early studies already pointed out the robust neurotrophic and neuroprotective effects of PACAP in vitro and in vivo through a combination of antiapototic, anti-inflammatory, and antioxidant effects. Although originally isolated from the central nervous system, and although early studies showed highest concentration in the brain, PACAP also has a very widespread occurrence in peripheral organs. Numerous studies have provided proof that PACAP exerts trophic and protective effects not only in the nervous system but also in several peripheral cell types and organs. The general cytoprotective effects of the peptide also point to the potential of PACAP as a therapeutic agent in numerous toxic, traumatic or ischemic injuries of different cells and tissues. Related peptides, especially VIP, have also been proven to act as protective factors in different cellular and animal models.
The aim of this Special Issue is to gather original and review papers on the general cytoprotective effects of PACAP and related peptides. In vitro, in vivo, and human studies with potential medical importance are all welcome.
Dr. Dora Reglodi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cellular protection